Unknown PHASE4 INTERVENTIONAL NCT00750217

Transfer From Methadone to Buprenorphine Maintenance Treatment Using Buprenorphine Patches

Transfer From Methadone to Buprenorphine Maintenance Treatment Using Buprenorphine Patches: A Study on Practicability With Patients Maintained With Daily Dosages Between 60mg and 100mg Methadone.

Sponsor: Psychiatric University Hospital, Zurich

Conditions Heroin Addiction

Interventions Buprenorphine patch and sublingual tablets

Updated 5 times since 2017 Last updated: Sep 9, 2008 Started: Aug 31, 2008 Primary completion: Feb 28, 2009 Completion: May 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Heroin Addiction, this trial is ongoing. The trial is conducted by Psychiatric University Hospital, Zurich and has accumulated 5 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Aug 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Psychiatric University Hospital, Zurich

Data source: Psychiatric University Hospital, Zurich

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zurich, Switzerland